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Background: The inevitable post-inflammatory fibrosis and adhesion often compromises future treatment in
peritoneal dialysis patients. Here, we describe a patient who experienced an unusual form of peritoneal adhesion
that made her give up peritoneal dialysis. However, its unique pattern also saved her from infection caused by
bowel perforation.
Case presentation: The female patient discontinued peritoneal dialysis due to gradual dialysis inadequacy. Two
months after shifting to hemodialysis with generally improved sense of well-being and no sign of abdominal
illness, she was admitted to remove the Tenckhoff catheter. The procedure was smooth, but fever and abdominal
pain not at the site of operation developed the next day. Abdominal ultrasound showed the presence of ascites
and aspiration revealed slimy, green-yellowish pus that gave a negative result on bacterial culture. Abdominal
computed tomography (CT) with oral contrast medium was performed, but failed to demonstrate the suspected
bowel perforation. The examination, however, did show accumulation of pus inside the abdomen but outside the
peritoneal cavity. We drained the pus with two 14-F Pig-tail catheters and the total amount of drainage
approached 4000 ml. The second CT was performed with double dose of the contrast medium and found a leak of
the contrast from the jejunum. She then received laparotomy and had the perforation site closed.
Conclusions: In summary, this uremic patient suffered from pus accumulation inside her abdomen without
obvious systemic toxic effect. The bowel perforation and pus formation might be caused by repeated peritonitis,
but the peritoneal adhesion itself might also isolate her peritoneal cavity from the anticipated toxic injuries of
bowel perforation.
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Peritoneal dialysis (PD) is a modality chosen by approxi-
mately 11% of end-stage renal disease (ESRD) patients in
2004 and 15.8% in 2009 globally [1]. The primary advan-
tage of PD is patients’ ability to undertake treatment
without having to visit a medical facility frequently. It has
comparable risks attributed to the permanent catheter
that may introduce bacteria into the abdomen and cause
peritonitis, the most common acute complication of PD
[2]. PD-related peritonitis is largely caused by cutaneous* Correspondence: jemich@kmu.edu.tw
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reproduction in any medium, provided the orGram’s (+) bacteria, although Gram’s (−) bacteria peri-
tonitis has become more and more common, and can
usually be treated effectively by appropriate antibiotics
[3]. However, the inevitable post-inflammatory fibrosis
and adhesion often compromise patients’ future treat-
ment. Manifestations of impaired peritoneal function in-
clude ultrafiltration failure, PD inadequacy, abdominal
symptoms of bowel obstruction, and malnutrition, thus
threatening patients’ lives [4]. The most severe form esti-
mated to occur in roughly 2.5% of patients is encapsulat-
ing peritoneal sclerosis (EPS), in which the bowels
become obstructed due to the growth of a thick layer of
collagen within the peritoneum [5]. Mortality rate of EPS
can be as high as 50%. The management of peritoneal
fibrosis and adhesion itself is usually not effective enough
to restore the peritoneal function to its original level.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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quality assurance in PD practice and it also reflects faith-
fully whether the education offered to the patients and
prevention measures are successful [6].
Here, we describe a patient who experienced an un-
usual form of EPS that made her give up PD. However,
its unique pattern also saved her from infection caused
by bowel perforation.
Case presentation
The female patient has been followed up for chronic
glomerulonephritis for several years before she finally
decided to take continuous ambulatory PD (CAPD) as
her renal replacement therapy. Her CAPD continued
uneventfully for more than seven years until she had the
first peritonitis caused by Staphylococcus aureus. It was
successfully treated with intraperitoneal cephalosporin
antibiotics for ten days and left no significant clinical
complication. The second peritonitis was noted in more
than one year after the first. Pseudomonas aeruginosa
was cultured from the dialysate and her abdominal
symptoms were severe. She did not agree to the sugges-
tion to remove the catheter and instead, was treated
with both intraperitoneal and intravenous ceftazidime.
The treatment course lasted for almost one month, but
eventually her abdominal symptoms gradually improved
and the dialysate became clear. She went on caring for
herself with CAPD in the following year. However, drain
of dialysate gradually became inadequate and peripheral
edema developed. Her body weight was not increased
(39–40 Kg) despite of the presence of marked edema.
Ultrafiltration failure caused by peritoneal adhesion wasFigure 1 A and B. Large amount of pus (*). The pus was located inside
peritoneal calcifications were seen (arrow), most likely due to the sequel ofdiagnosed and she finally consented to giving up CAPD
and shifting to hemodialysis (HD), three times a week
and 3.5 hours per session. Drainage fluid of PD solutions
had been clear in every exchange till the termination of
PD treatment. HD went on smoothly and removed all
the accumulated edema until her body weight became
33 Kg. She regained her appetite and her body weight
gradually increased to 36–37 Kg in the following six
weeks. General sense of well-being improved signifi-
cantly and she was able to go abroad twice for three-day
tours. She was then admitted to remove the PD Tenckh-
off catheter after maintaining stable HD for two months.
The operation was successful but unfortunately, fever up
to 38.7°C was noted the next day. Blood leukocyte count
was 10780 per ml and C-reactive protein was 129 mg/dl.
Oral acetaminophen and intravenous broad-spectrum
antibiotics were given under the suspicion of procedure-
related infection and blood was sent to the laboratory
for culture which gave negative result. Fever subsided
after two days, but she started to complain of abdominal
pain and tenderness, not at the site of operation.
Abdominal ultrasound was performed and showed large
amount of ascites. Bedside paracentesis with 19-F
syringe revealed slimy green-yellowish pus which was
immediately sent to the laboratory for microbial analysis.
Surprisingly, the microscopic and culture examination
reported negative for any bacteria. For detailed anatomic
analysis and further management, she received abdom-
inal computed tomography (CT) examination which
suggested the formation of a cocoon wrapping the intes-
tines. Large amount of ascites (with much higher CT
number than water) was shown outside the cocoonthe abdomen but did not involve the peritoneal cavity. Several
previous peritonitis.
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placed to drain the pus. The total amount of drainage (by
two catheters) in the following seven days approached
4000 ml. Repeated CT examination while the patient
ingesting 200 ml UltravistW contrast medium was per-
formed to locate the suspicious bowel perforation, but the
result was inconclusive (Figure 2A and 2B). We discontin-
ued the antibiotic treatment and removed the catheters
after a near-complete drainage and arranged another CT
scan with the patient ingesting 400 ml contrast medium.
The ingested medium was found to leak from the jejunum
and spread under the abdominal wall as a thin layer
(Figure 3A-C), but not inside the peritoneal cavity. She
then received a laparotomy and extensive adhesion of the
visceral peritoneal membrane that wrapped all the intes-
tines into a cocoon-like pattern was seen during oper-
ation, along with a small amount of residual ascites
outside the cocoon. The surgeon successfully located a
small perforation that matched the suspected leakage site
and closed it directly. She recovered quickly from the pro-
cedure with no sign of infection. Regular maintenance HD
was given and both her appetite and nutritional status
were improved.Figure 2 A and B. Repeated CT scan with patient ingesting 200 ml of
showed suspicious medium leak (arrow) but the amount was small and inc
drained.Six months after surgery, her body weight increased
gradually to 37–38 Kg. There was no edema, and
abdominal symptoms were absent.
Conclusions
In this article, we described an unusual clinical course of
a CAPD patient who suffered from peritoneal adhesion
due to CAPD-related peritonitis. The complication was
serious enough to compromise her CAPD, but was so
specific that it prevents the invasion of a potentially le-
thal infection.
Peritonitis remains a leading complication of PD and
contributes greatly to morbidity and mortality of PD
patients [7]. Severe peritonitis can cause peritoneal mem-
brane failure and stays as the major cause of discontinuing
PD and shifting to HD. Peritonitis infected by Gram’s (−)
bacteria has become more common, although Gram’s (+)
organisms remain the major causes [3]. Previous study has
shown that Pseudomonas aeruginosa peritonitis is generally
severe and associated with longer duration of admission,
more severe peritoneal membrane damage, and higher rate
of catheter removal and transfer to HD [8]. Therefore,
some even suggested prompt catheter removal uponUltravistW medium. Both transverse (A) and sagittal (B) sections
onclusive to reveal the site of leakage. The pus (*) had been partially
Figure 3 A, B and C. Peated CT scan when pus was completely drained and patient ingested 400 ml of UltravistW medium. The
transverse image suggested a cocoon-like conformation which kept the leaking medium from entering the peritoneal cavity (arrow in Figure 3A
and 3C). Figure 3B shows the favored site of perforation (solid arrow) near the original exit site of PD catheter (dotted arrow). It was later proved
by the laparotomy finding.
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[9]. Our patient, in her second peritonitis event, was suc-
cessfully treated with antibiotics for one month and contin-
ued her PD treatment. However, PD inadequacy soon
became evident and this was also proved by follow-up peri-
toneum equilibration test. Her Kt/V decreased from 1.99
to 1.44, and weekly creatinine clearance dropped from 56
liters per week to 41 liters per week. These findings and se-
vere edema persuaded her to switch to HD.
We had cautiously considered the possible diagnosis
of encapsulated peritoneal sclerosis (EPS), the most ser-
ious complication of long-term PD therapy, because the
treatment of EPS was usually unsatisfactory and out-
come could be poor with high mortality rate [10]. This
patient presented several risk factors associated with
EPS development, including long duration of PD, young
age, exclusive use of dextrose solution, peritonitis, and
late ultrafiltration failure. She also suffered from gradual
reduction of appetite, progressive weight loss (obvious
peripheral edema but unvarying body weight), malnutri-
tion (serum albumin < 3.5 g/dl for almost a year before
shifting to HD), and favorable structural finding noted
during laparotomy. However, she did not experience
symptoms and signs of bowel obstruction that are com-
mon in patients with severe EPS, such as progressive ab-
dominal pain, abdominal distention, or difficulties in
defecation. The poor appetite and peripheral edema
were effectively corrected by changing treatment modal-
ity without specific treatment for EPS, such as enteroly-
sis [11], tamoxifen [12], or immunosuppressive agents
[13]. In the most severe form of EPS, a sclerotic layermay completely cover the intestines, which gives them
the appearance of a cocoon. The CT images supported
the diagnosis of EPS and cocoon formation, but they
also showed that the adhesion and fibrosis were rela-
tively mild in the peritoneum between intestines. This
might partly explain the absence of excruciating abdom-
inal symptoms of bowel obstruction.
This patient did not experience any traumatic event
that might lead to her bowel perforation. The most rea-
sonable explanation would still be the adhesion between
the intestines and abdominal wall at the insertion site.
She had kept her Tenckhoff catheter for about two
months before removal. With hindsight, the catheter
might have been pulled unintentionally, thus tearing and
bowel wall. Nevertheless, the tear was too small to cause
significant abdominal symptoms, as shown by the clin-
ical wellness and improvement in the period before
Tenckhoff catheter removal. The leakage still was mani-
fested by large amount of intra-abdominal pus accumu-
lating gradually between the parietal and visceral
peritoneal membranes, within the same period of time.
It’s very likely that the peritoneal cavity was completely
covered by a fibrotic layer and the pus did not gain ac-
cess into the intestinal loops. Therefore, this patient
could live a life of wellness devoid of any significant
gastrointestinal symptoms in those two months of HD.
Pus was later drained smoothly with pigtail catheters
and the bowel perforation was then successfully closed.
In summary, this patient had suffered from peritonitis-
related peritoneal adhesion severe enough to cause ultra-
filtration failure that made her change dialysis modality.
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Nevertheless, the pattern of adhesion was so specific
that kept the pus out of her intestinal loops and salvaged
her from the anticipated abdominal catastrophe.
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